nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomifene—ABCB1—melanoma	0.189	1	CbGaD
Clomifene—CYP1A1—Dacarbazine—melanoma	0.102	0.199	CbGbCtD
Clomifene—CYP2E1—Dacarbazine—melanoma	0.0786	0.154	CbGbCtD
Clomifene—CYP1A2—Carmustine—melanoma	0.075	0.147	CbGbCtD
Clomifene—CYP1A2—Vemurafenib—melanoma	0.0593	0.116	CbGbCtD
Clomifene—CYP3A4—Temozolomide—melanoma	0.0567	0.111	CbGbCtD
Clomifene—CYP1A2—Dacarbazine—melanoma	0.0454	0.089	CbGbCtD
Clomifene—ABCB1—Dactinomycin—melanoma	0.0345	0.0675	CbGbCtD
Clomifene—CYP3A4—Vemurafenib—melanoma	0.0311	0.0608	CbGbCtD
Clomifene—Brain abscess—Carmustine—melanoma	0.0231	0.124	CcSEcCtD
Clomifene—Astrocytoma—Temozolomide—melanoma	0.0224	0.12	CcSEcCtD
Clomifene—ABCB1—Docetaxel—melanoma	0.0178	0.0348	CbGbCtD
Clomifene—CYP3A4—Docetaxel—melanoma	0.0107	0.0209	CbGbCtD
Clomifene—Hydrocephalus—Carmustine—melanoma	0.00849	0.0455	CcSEcCtD
Clomifene—Ichthyosis acquired—Bleomycin—melanoma	0.00796	0.0426	CcSEcCtD
Clomifene—Ichthyosis—Bleomycin—melanoma	0.00796	0.0426	CcSEcCtD
Clomifene—Malignant melanoma—Vemurafenib—melanoma	0.0058	0.0311	CcSEcCtD
Clomifene—Carcinoma breast—Docetaxel—melanoma	0.0038	0.0204	CcSEcCtD
Clomifene—Erythema nodosum—Vemurafenib—melanoma	0.0035	0.0187	CcSEcCtD
Clomifene—Ovarian cancer—Docetaxel—melanoma	0.00297	0.0159	CcSEcCtD
Clomifene—Retinal haemorrhage—Carmustine—melanoma	0.00246	0.0132	CcSEcCtD
Clomifene—Vasospasm—Carmustine—melanoma	0.00234	0.0126	CcSEcCtD
Clomifene—Cyst—Vemurafenib—melanoma	0.00226	0.0121	CcSEcCtD
Clomifene—Thromboembolic event—Docetaxel—melanoma	0.00191	0.0102	CcSEcCtD
Clomifene—Ascites—Dactinomycin—melanoma	0.00188	0.0101	CcSEcCtD
Clomifene—Disorder sight—Temozolomide—melanoma	0.00162	0.0087	CcSEcCtD
Clomifene—Photopsia—Docetaxel—melanoma	0.00162	0.00867	CcSEcCtD
Clomifene—Procaine—SCN10A—melanoma	0.00148	0.651	CrCbGaD
Clomifene—Breast cancer—Docetaxel—melanoma	0.00141	0.00755	CcSEcCtD
Clomifene—Neoplasm—Vemurafenib—melanoma	0.00137	0.00733	CcSEcCtD
Clomifene—Transaminases increased—Carmustine—melanoma	0.00132	0.00705	CcSEcCtD
Clomifene—Visual acuity reduced—Temozolomide—melanoma	0.0013	0.00697	CcSEcCtD
Clomifene—Embolism—Temozolomide—melanoma	0.00121	0.00646	CcSEcCtD
Clomifene—Cyst—Carmustine—melanoma	0.0012	0.00642	CcSEcCtD
Clomifene—Ascites—Docetaxel—melanoma	0.00113	0.00606	CcSEcCtD
Clomifene—Thrombosis—Carmustine—melanoma	0.00113	0.00606	CcSEcCtD
Clomifene—Myopathy—Temozolomide—melanoma	0.0011	0.00591	CcSEcCtD
Clomifene—Scotoma—Carmustine—melanoma	0.00105	0.00565	CcSEcCtD
Clomifene—Tenderness—Bleomycin—melanoma	0.00105	0.00563	CcSEcCtD
Clomifene—Menorrhagia—Temozolomide—melanoma	0.00105	0.0056	CcSEcCtD
Clomifene—Cholestasis—Temozolomide—melanoma	0.00102	0.00546	CcSEcCtD
Clomifene—Scotoma—Temozolomide—melanoma	0.00102	0.00546	CcSEcCtD
Clomifene—Foetor hepaticus—Docetaxel—melanoma	0.000907	0.00486	CcSEcCtD
Clomifene—Leukocytosis—Carmustine—melanoma	0.000852	0.00456	CcSEcCtD
Clomifene—Embolism—Docetaxel—melanoma	0.000801	0.00429	CcSEcCtD
Clomifene—Pulmonary embolism—Carmustine—melanoma	0.0008	0.00429	CcSEcCtD
Clomifene—Pulmonary embolism—Temozolomide—melanoma	0.000774	0.00414	CcSEcCtD
Clomifene—Phlebitis—Bleomycin—melanoma	0.000773	0.00414	CcSEcCtD
Clomifene—Cyst—Docetaxel—melanoma	0.00077	0.00412	CcSEcCtD
Clomifene—Liver disorder—Docetaxel—melanoma	0.000755	0.00404	CcSEcCtD
Clomifene—Neoplasm—Carmustine—melanoma	0.000724	0.00388	CcSEcCtD
Clomifene—Phlebitis—Dactinomycin—melanoma	0.000721	0.00386	CcSEcCtD
Clomifene—Erythema multiforme—Vemurafenib—melanoma	0.000719	0.00385	CcSEcCtD
Clomifene—Neoplasm—Temozolomide—melanoma	0.000699	0.00375	CcSEcCtD
Clomifene—Dermatitis atopic—Docetaxel—melanoma	0.000695	0.00372	CcSEcCtD
Clomifene—Mental disability—Carmustine—melanoma	0.000695	0.00372	CcSEcCtD
Clomifene—Cerebrovascular accident—Bleomycin—melanoma	0.000679	0.00364	CcSEcCtD
Clomifene—Scotoma—Docetaxel—melanoma	0.000677	0.00363	CcSEcCtD
Clomifene—Phlebitis—Carmustine—melanoma	0.000674	0.00361	CcSEcCtD
Clomifene—Alopecia—Vemurafenib—melanoma	0.000672	0.0036	CcSEcCtD
Clomifene—Mental disability—Temozolomide—melanoma	0.000671	0.0036	CcSEcCtD
Clomifene—Thrombophlebitis—Carmustine—melanoma	0.000671	0.0036	CcSEcCtD
Clomifene—Erythema—Vemurafenib—melanoma	0.000662	0.00354	CcSEcCtD
Clomifene—Thrombophlebitis—Temozolomide—melanoma	0.000649	0.00348	CcSEcCtD
Clomifene—Eye pain—Carmustine—melanoma	0.000644	0.00345	CcSEcCtD
Clomifene—Back pain—Vemurafenib—melanoma	0.00064	0.00343	CcSEcCtD
Clomifene—Deafness—Temozolomide—melanoma	0.000628	0.00336	CcSEcCtD
Clomifene—Eye pain—Temozolomide—melanoma	0.000622	0.00333	CcSEcCtD
Clomifene—Hot flush—Temozolomide—melanoma	0.0006	0.00322	CcSEcCtD
Clomifene—Menopausal symptoms—Temozolomide—melanoma	0.000595	0.00319	CcSEcCtD
Clomifene—Diplopia—Carmustine—melanoma	0.000581	0.00311	CcSEcCtD
Clomifene—Myalgia—Vemurafenib—melanoma	0.000563	0.00302	CcSEcCtD
Clomifene—Arthralgia—Vemurafenib—melanoma	0.000563	0.00302	CcSEcCtD
Clomifene—Diplopia—Temozolomide—melanoma	0.000562	0.00301	CcSEcCtD
Clomifene—Affect lability—Temozolomide—melanoma	0.000553	0.00296	CcSEcCtD
Clomifene—Mood swings—Temozolomide—melanoma	0.000532	0.00285	CcSEcCtD
Clomifene—Hepatocellular injury—Docetaxel—melanoma	0.000514	0.00276	CcSEcCtD
Clomifene—Pulmonary embolism—Docetaxel—melanoma	0.000514	0.00276	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000492	0.00264	CcSEcCtD
Clomifene—Abdominal distension—Temozolomide—melanoma	0.000489	0.00262	CcSEcCtD
Clomifene—Fatigue—Vemurafenib—melanoma	0.000466	0.00249	CcSEcCtD
Clomifene—Neoplasm—Docetaxel—melanoma	0.000465	0.00249	CcSEcCtD
Clomifene—Constipation—Vemurafenib—melanoma	0.000462	0.00247	CcSEcCtD
Clomifene—Lightheadedness—Docetaxel—melanoma	0.00046	0.00247	CcSEcCtD
Clomifene—Pollakiuria—Temozolomide—melanoma	0.000448	0.0024	CcSEcCtD
Clomifene—Weight increased—Temozolomide—melanoma	0.000442	0.00237	CcSEcCtD
Clomifene—Renal failure—Carmustine—melanoma	0.00044	0.00236	CcSEcCtD
Clomifene—Phlebitis—Docetaxel—melanoma	0.000433	0.00232	CcSEcCtD
Clomifene—Thrombophlebitis—Docetaxel—melanoma	0.000431	0.00231	CcSEcCtD
Clomifene—Hepatitis—Dactinomycin—melanoma	0.000429	0.0023	CcSEcCtD
Clomifene—Flushing—Bleomycin—melanoma	0.000427	0.00229	CcSEcCtD
Clomifene—Body temperature increased—Vemurafenib—melanoma	0.000427	0.00229	CcSEcCtD
Clomifene—Deafness—Docetaxel—melanoma	0.000417	0.00224	CcSEcCtD
Clomifene—Alopecia—Bleomycin—melanoma	0.000407	0.00218	CcSEcCtD
Clomifene—Erythema multiforme—Dactinomycin—melanoma	0.000406	0.00218	CcSEcCtD
Clomifene—Erythema—Bleomycin—melanoma	0.000401	0.00215	CcSEcCtD
Clomifene—Hot flush—Docetaxel—melanoma	0.000399	0.00214	CcSEcCtD
Clomifene—Flushing—Dactinomycin—melanoma	0.000399	0.00214	CcSEcCtD
Clomifene—Hypersensitivity—Vemurafenib—melanoma	0.000398	0.00213	CcSEcCtD
Clomifene—Tamoxifen—CYP1B1—melanoma	0.000396	0.174	CrCbGaD
Clomifene—Menopausal symptoms—Docetaxel—melanoma	0.000396	0.00212	CcSEcCtD
Clomifene—Visual disturbance—Docetaxel—melanoma	0.000394	0.00211	CcSEcCtD
Clomifene—Hepatitis—Temozolomide—melanoma	0.000388	0.00208	CcSEcCtD
Clomifene—Asthenia—Vemurafenib—melanoma	0.000387	0.00208	CcSEcCtD
Clomifene—Visual impairment—Carmustine—melanoma	0.000387	0.00208	CcSEcCtD
Clomifene—Pruritus—Vemurafenib—melanoma	0.000382	0.00205	CcSEcCtD
Clomifene—Alopecia—Dactinomycin—melanoma	0.00038	0.00203	CcSEcCtD
Clomifene—Visual impairment—Temozolomide—melanoma	0.000374	0.00201	CcSEcCtD
Clomifene—Erythema—Dactinomycin—melanoma	0.000374	0.002	CcSEcCtD
Clomifene—Flushing—Carmustine—melanoma	0.000373	0.002	CcSEcCtD
Clomifene—Diarrhoea—Vemurafenib—melanoma	0.000369	0.00198	CcSEcCtD
Clomifene—Migraine—Docetaxel—melanoma	0.000368	0.00197	CcSEcCtD
Clomifene—Erythema multiforme—Temozolomide—melanoma	0.000367	0.00197	CcSEcCtD
Clomifene—Tinnitus—Temozolomide—melanoma	0.000362	0.00194	CcSEcCtD
Clomifene—Flushing—Temozolomide—melanoma	0.000361	0.00193	CcSEcCtD
Clomifene—Arrhythmia—Carmustine—melanoma	0.000359	0.00192	CcSEcCtD
Clomifene—Dizziness—Vemurafenib—melanoma	0.000357	0.00191	CcSEcCtD
Clomifene—Alopecia—Carmustine—melanoma	0.000355	0.0019	CcSEcCtD
Clomifene—Erythema—Carmustine—melanoma	0.00035	0.00187	CcSEcCtD
Clomifene—Vomiting—Vemurafenib—melanoma	0.000343	0.00184	CcSEcCtD
Clomifene—Alopecia—Temozolomide—melanoma	0.000343	0.00184	CcSEcCtD
Clomifene—Myalgia—Bleomycin—melanoma	0.000341	0.00183	CcSEcCtD
Clomifene—Chest pain—Bleomycin—melanoma	0.000341	0.00183	CcSEcCtD
Clomifene—Rash—Vemurafenib—melanoma	0.00034	0.00182	CcSEcCtD
Clomifene—Dermatitis—Vemurafenib—melanoma	0.00034	0.00182	CcSEcCtD
Clomifene—Back pain—Carmustine—melanoma	0.000338	0.00181	CcSEcCtD
Clomifene—Headache—Vemurafenib—melanoma	0.000338	0.00181	CcSEcCtD
Clomifene—Erythema—Temozolomide—melanoma	0.000338	0.00181	CcSEcCtD
Clomifene—Vision blurred—Carmustine—melanoma	0.00033	0.00177	CcSEcCtD
Clomifene—Oedema—Bleomycin—melanoma	0.000327	0.00175	CcSEcCtD
Clomifene—Back pain—Temozolomide—melanoma	0.000327	0.00175	CcSEcCtD
Clomifene—Nausea—Vemurafenib—melanoma	0.000321	0.00172	CcSEcCtD
Clomifene—Vision blurred—Temozolomide—melanoma	0.000319	0.00171	CcSEcCtD
Clomifene—Myalgia—Dactinomycin—melanoma	0.000318	0.00171	CcSEcCtD
Clomifene—Oedema—Dactinomycin—melanoma	0.000305	0.00163	CcSEcCtD
Clomifene—Vertigo—Temozolomide—melanoma	0.000304	0.00163	CcSEcCtD
Clomifene—Convulsion—Carmustine—melanoma	0.000303	0.00162	CcSEcCtD
Clomifene—Hypertension—Carmustine—melanoma	0.000302	0.00162	CcSEcCtD
Clomifene—Palpitations—Temozolomide—melanoma	0.000299	0.0016	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Bleomycin—melanoma	0.000298	0.0016	CcSEcCtD
Clomifene—Chest pain—Carmustine—melanoma	0.000298	0.0016	CcSEcCtD
Clomifene—Myalgia—Carmustine—melanoma	0.000298	0.0016	CcSEcCtD
Clomifene—Anxiety—Carmustine—melanoma	0.000297	0.00159	CcSEcCtD
Clomifene—Paraesthesia—Bleomycin—melanoma	0.000294	0.00157	CcSEcCtD
Clomifene—Weight increased—Docetaxel—melanoma	0.000294	0.00157	CcSEcCtD
Clomifene—Convulsion—Temozolomide—melanoma	0.000293	0.00157	CcSEcCtD
Clomifene—Hypertension—Temozolomide—melanoma	0.000292	0.00156	CcSEcCtD
Clomifene—Dyspnoea—Bleomycin—melanoma	0.000292	0.00156	CcSEcCtD
Clomifene—Myalgia—Temozolomide—melanoma	0.000288	0.00154	CcSEcCtD
Clomifene—Arthralgia—Temozolomide—melanoma	0.000288	0.00154	CcSEcCtD
Clomifene—Anxiety—Temozolomide—melanoma	0.000287	0.00154	CcSEcCtD
Clomifene—Oedema—Carmustine—melanoma	0.000286	0.00153	CcSEcCtD
Clomifene—Toremifene—ABCB1—melanoma	0.000285	0.125	CrCbGaD
Clomifene—Renal failure—Docetaxel—melanoma	0.000283	0.00152	CcSEcCtD
Clomifene—Jaundice—Docetaxel—melanoma	0.00028	0.0015	CcSEcCtD
Clomifene—Pain—Bleomycin—melanoma	0.00028	0.0015	CcSEcCtD
Clomifene—Tachycardia—Carmustine—melanoma	0.000279	0.00149	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000278	0.00149	CcSEcCtD
Clomifene—Oedema—Temozolomide—melanoma	0.000276	0.00148	CcSEcCtD
Clomifene—Fatigue—Dactinomycin—melanoma	0.000263	0.00141	CcSEcCtD
Clomifene—Pain—Dactinomycin—melanoma	0.000261	0.0014	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Carmustine—melanoma	0.00026	0.00139	CcSEcCtD
Clomifene—Urticaria—Bleomycin—melanoma	0.00026	0.00139	CcSEcCtD
Clomifene—Body temperature increased—Bleomycin—melanoma	0.000259	0.00139	CcSEcCtD
Clomifene—Hepatitis—Docetaxel—melanoma	0.000258	0.00138	CcSEcCtD
Clomifene—Insomnia—Carmustine—melanoma	0.000258	0.00138	CcSEcCtD
Clomifene—Paraesthesia—Carmustine—melanoma	0.000256	0.00137	CcSEcCtD
Clomifene—Dyspnoea—Carmustine—melanoma	0.000255	0.00136	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Temozolomide—melanoma	0.000251	0.00135	CcSEcCtD
Clomifene—Insomnia—Temozolomide—melanoma	0.00025	0.00134	CcSEcCtD
Clomifene—Visual impairment—Docetaxel—melanoma	0.000249	0.00133	CcSEcCtD
Clomifene—Paraesthesia—Temozolomide—melanoma	0.000248	0.00133	CcSEcCtD
Clomifene—Dyspnoea—Temozolomide—melanoma	0.000246	0.00132	CcSEcCtD
Clomifene—Erythema multiforme—Docetaxel—melanoma	0.000244	0.00131	CcSEcCtD
Clomifene—Constipation—Carmustine—melanoma	0.000244	0.00131	CcSEcCtD
Clomifene—Pain—Carmustine—melanoma	0.000244	0.00131	CcSEcCtD
Clomifene—Body temperature increased—Dactinomycin—melanoma	0.000241	0.00129	CcSEcCtD
Clomifene—Hypersensitivity—Bleomycin—melanoma	0.000241	0.00129	CcSEcCtD
Clomifene—Flushing—Docetaxel—melanoma	0.00024	0.00128	CcSEcCtD
Clomifene—Fatigue—Temozolomide—melanoma	0.000238	0.00127	CcSEcCtD
Clomifene—Pain—Temozolomide—melanoma	0.000236	0.00126	CcSEcCtD
Clomifene—Constipation—Temozolomide—melanoma	0.000236	0.00126	CcSEcCtD
Clomifene—Asthenia—Bleomycin—melanoma	0.000235	0.00126	CcSEcCtD
Clomifene—Pruritus—Bleomycin—melanoma	0.000231	0.00124	CcSEcCtD
Clomifene—Arrhythmia—Docetaxel—melanoma	0.000231	0.00124	CcSEcCtD
Clomifene—Alopecia—Docetaxel—melanoma	0.000228	0.00122	CcSEcCtD
Clomifene—Body temperature increased—Carmustine—melanoma	0.000226	0.00121	CcSEcCtD
Clomifene—Erythema—Docetaxel—melanoma	0.000225	0.0012	CcSEcCtD
Clomifene—Hypersensitivity—Dactinomycin—melanoma	0.000225	0.0012	CcSEcCtD
Clomifene—Urticaria—Temozolomide—melanoma	0.000219	0.00117	CcSEcCtD
Clomifene—Asthenia—Dactinomycin—melanoma	0.000219	0.00117	CcSEcCtD
Clomifene—Body temperature increased—Temozolomide—melanoma	0.000218	0.00117	CcSEcCtD
Clomifene—Back pain—Docetaxel—melanoma	0.000218	0.00117	CcSEcCtD
Clomifene—Hypersensitivity—Carmustine—melanoma	0.00021	0.00113	CcSEcCtD
Clomifene—Diarrhoea—Dactinomycin—melanoma	0.000209	0.00112	CcSEcCtD
Clomifene—Vomiting—Bleomycin—melanoma	0.000208	0.00111	CcSEcCtD
Clomifene—Rash—Bleomycin—melanoma	0.000206	0.00111	CcSEcCtD
Clomifene—Dermatitis—Bleomycin—melanoma	0.000206	0.0011	CcSEcCtD
Clomifene—Asthenia—Carmustine—melanoma	0.000205	0.0011	CcSEcCtD
Clomifene—Hypersensitivity—Temozolomide—melanoma	0.000203	0.00109	CcSEcCtD
Clomifene—Syncope—Docetaxel—melanoma	0.000202	0.00108	CcSEcCtD
Clomifene—Palpitations—Docetaxel—melanoma	0.000199	0.00106	CcSEcCtD
Clomifene—Asthenia—Temozolomide—melanoma	0.000198	0.00106	CcSEcCtD
Clomifene—Loss of consciousness—Docetaxel—melanoma	0.000198	0.00106	CcSEcCtD
Clomifene—Diarrhoea—Carmustine—melanoma	0.000195	0.00105	CcSEcCtD
Clomifene—Pruritus—Temozolomide—melanoma	0.000195	0.00105	CcSEcCtD
Clomifene—Convulsion—Docetaxel—melanoma	0.000195	0.00104	CcSEcCtD
Clomifene—Nausea—Bleomycin—melanoma	0.000194	0.00104	CcSEcCtD
Clomifene—Hypertension—Docetaxel—melanoma	0.000194	0.00104	CcSEcCtD
Clomifene—Vomiting—Dactinomycin—melanoma	0.000194	0.00104	CcSEcCtD
Clomifene—Rash—Dactinomycin—melanoma	0.000192	0.00103	CcSEcCtD
Clomifene—Arthralgia—Docetaxel—melanoma	0.000191	0.00103	CcSEcCtD
Clomifene—Chest pain—Docetaxel—melanoma	0.000191	0.00103	CcSEcCtD
Clomifene—Myalgia—Docetaxel—melanoma	0.000191	0.00103	CcSEcCtD
Clomifene—Dizziness—Carmustine—melanoma	0.000189	0.00101	CcSEcCtD
Clomifene—Diarrhoea—Temozolomide—melanoma	0.000189	0.00101	CcSEcCtD
Clomifene—Oedema—Docetaxel—melanoma	0.000184	0.000983	CcSEcCtD
Clomifene—Dizziness—Temozolomide—melanoma	0.000182	0.000978	CcSEcCtD
Clomifene—Vomiting—Carmustine—melanoma	0.000182	0.000973	CcSEcCtD
Clomifene—Nausea—Dactinomycin—melanoma	0.000181	0.000971	CcSEcCtD
Clomifene—Shock—Docetaxel—melanoma	0.000181	0.000967	CcSEcCtD
Clomifene—Rash—Carmustine—melanoma	0.00018	0.000965	CcSEcCtD
Clomifene—Dermatitis—Carmustine—melanoma	0.00018	0.000964	CcSEcCtD
Clomifene—Tachycardia—Docetaxel—melanoma	0.000179	0.00096	CcSEcCtD
Clomifene—Headache—Carmustine—melanoma	0.000179	0.000958	CcSEcCtD
Clomifene—Vomiting—Temozolomide—melanoma	0.000175	0.00094	CcSEcCtD
Clomifene—Rash—Temozolomide—melanoma	0.000174	0.000932	CcSEcCtD
Clomifene—Dermatitis—Temozolomide—melanoma	0.000174	0.000931	CcSEcCtD
Clomifene—Headache—Temozolomide—melanoma	0.000173	0.000926	CcSEcCtD
Clomifene—Nausea—Carmustine—melanoma	0.00017	0.000909	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Docetaxel—melanoma	0.000167	0.000896	CcSEcCtD
Clomifene—Insomnia—Docetaxel—melanoma	0.000166	0.000889	CcSEcCtD
Clomifene—Paraesthesia—Docetaxel—melanoma	0.000165	0.000883	CcSEcCtD
Clomifene—Nausea—Temozolomide—melanoma	0.000164	0.000878	CcSEcCtD
Clomifene—Dyspnoea—Docetaxel—melanoma	0.000164	0.000877	CcSEcCtD
Clomifene—Fatigue—Docetaxel—melanoma	0.000158	0.000848	CcSEcCtD
Clomifene—Pain—Docetaxel—melanoma	0.000157	0.000841	CcSEcCtD
Clomifene—Constipation—Docetaxel—melanoma	0.000157	0.000841	CcSEcCtD
Clomifene—Body temperature increased—Docetaxel—melanoma	0.000145	0.000777	CcSEcCtD
Clomifene—Hypersensitivity—Docetaxel—melanoma	0.000135	0.000724	CcSEcCtD
Clomifene—Asthenia—Docetaxel—melanoma	0.000132	0.000705	CcSEcCtD
Clomifene—Pruritus—Docetaxel—melanoma	0.00013	0.000696	CcSEcCtD
Clomifene—Diarrhoea—Docetaxel—melanoma	0.000126	0.000673	CcSEcCtD
Clomifene—Dizziness—Docetaxel—melanoma	0.000121	0.00065	CcSEcCtD
Clomifene—Vomiting—Docetaxel—melanoma	0.000117	0.000625	CcSEcCtD
Clomifene—Rash—Docetaxel—melanoma	0.000116	0.00062	CcSEcCtD
Clomifene—Dermatitis—Docetaxel—melanoma	0.000116	0.000619	CcSEcCtD
Clomifene—Headache—Docetaxel—melanoma	0.000115	0.000616	CcSEcCtD
Clomifene—Tamoxifen—ABCB1—melanoma	0.000114	0.05	CrCbGaD
Clomifene—Nausea—Docetaxel—melanoma	0.000109	0.000584	CcSEcCtD
Clomifene—CYP2A6—Metabolism—CD44—melanoma	1.48e-05	0.000132	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—GNAQ—melanoma	1.48e-05	0.000132	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—ABCB1—melanoma	1.47e-05	0.000131	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	1.45e-05	0.00013	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	1.45e-05	0.00013	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—CYP1B1—melanoma	1.42e-05	0.000127	CbGpPWpGaD
Clomifene—EBP—Metabolism—AKT1—melanoma	1.41e-05	0.000126	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.41e-05	0.000126	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—FOXO4—melanoma	1.41e-05	0.000126	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—HDAC2—melanoma	1.41e-05	0.000126	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CXCR4—melanoma	1.41e-05	0.000126	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—PIK3CD—melanoma	1.4e-05	0.000125	CbGpPWpGaD
Clomifene—ESR1—Generic Transcription Pathway—MYC—melanoma	1.39e-05	0.000124	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—GNAQ—melanoma	1.39e-05	0.000124	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—ALB—melanoma	1.38e-05	0.000124	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	1.38e-05	0.000123	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PHGDH—melanoma	1.38e-05	0.000123	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—LUM—melanoma	1.38e-05	0.000123	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	1.37e-05	0.000122	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.36e-05	0.000121	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—HPSE—melanoma	1.35e-05	0.000121	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—PRKCA—melanoma	1.35e-05	0.000121	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—ERCC2—melanoma	1.34e-05	0.00012	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—CYP17A1—melanoma	1.33e-05	0.000119	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—CUBN—melanoma	1.33e-05	0.000119	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PLA2G6—melanoma	1.32e-05	0.000118	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—SYK—melanoma	1.31e-05	0.000117	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PLCB4—melanoma	1.3e-05	0.000117	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—AKT3—melanoma	1.28e-05	0.000115	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—ITGAV—melanoma	1.28e-05	0.000115	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—NGFR—melanoma	1.28e-05	0.000115	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—SDHD—melanoma	1.28e-05	0.000115	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—CSPG4—melanoma	1.28e-05	0.000115	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—BSG—melanoma	1.28e-05	0.000115	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	1.26e-05	0.000112	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—GNA11—melanoma	1.26e-05	0.000112	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—CYP17A1—melanoma	1.25e-05	0.000112	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—NOTCH1—melanoma	1.24e-05	0.000111	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—GPAM—melanoma	1.24e-05	0.000111	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.24e-05	0.000111	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—FASN—melanoma	1.23e-05	0.00011	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—SLC6A11—melanoma	1.23e-05	0.00011	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PIP4K2A—melanoma	1.23e-05	0.00011	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—PIK3CB—melanoma	1.22e-05	0.000109	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—ALB—melanoma	1.22e-05	0.000109	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	1.22e-05	0.000109	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—PTGS2—melanoma	1.21e-05	0.000108	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—SLC5A5—melanoma	1.21e-05	0.000108	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—MTAP—melanoma	1.19e-05	0.000107	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—SOCS1—melanoma	1.19e-05	0.000106	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—VCAN—melanoma	1.19e-05	0.000106	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—S100B—melanoma	1.18e-05	0.000106	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—GNA11—melanoma	1.18e-05	0.000106	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—PPARG—melanoma	1.17e-05	0.000105	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—GNAQ—melanoma	1.17e-05	0.000104	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—CD44—melanoma	1.17e-05	0.000104	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—ABCB1—melanoma	1.17e-05	0.000104	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—FASN—melanoma	1.16e-05	0.000104	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—SLC5A5—melanoma	1.14e-05	0.000102	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—ERBB4—melanoma	1.13e-05	0.000101	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CDKN2B—melanoma	1.12e-05	0.0001	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—CYP1B1—melanoma	1.12e-05	0.0001	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.11e-05	9.91e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—CD44—melanoma	1.1e-05	9.85e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—GNAQ—melanoma	1.1e-05	9.85e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CD86—melanoma	1.09e-05	9.72e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.08e-05	9.64e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—EDN1—melanoma	1.08e-05	9.64e-05	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—PRKCA—melanoma	1.07e-05	9.6e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.07e-05	9.55e-05	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—ERCC2—melanoma	1.06e-05	9.52e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PHGDH—melanoma	1.06e-05	9.51e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—LUM—melanoma	1.06e-05	9.51e-05	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—PIK3CG—melanoma	1.06e-05	9.45e-05	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—PTEN—melanoma	1.06e-05	9.45e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—CYP1B1—melanoma	1.06e-05	9.44e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PLA2G6—melanoma	1.05e-05	9.44e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CSF2—melanoma	1.05e-05	9.42e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—FGF1—melanoma	1.05e-05	9.42e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—HPSE—melanoma	1.04e-05	9.33e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—E2F1—melanoma	1.03e-05	9.22e-05	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	1.03e-05	9.19e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—CUBN—melanoma	1.02e-05	9.16e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PDGFRA—melanoma	1.02e-05	9.12e-05	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—PPARG—melanoma	1.02e-05	9.12e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—ITGB3—melanoma	1.01e-05	9.03e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PRKCA—melanoma	1.01e-05	9.03e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—CYP17A1—melanoma	1e-05	8.96e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—SPP1—melanoma	9.9e-06	8.86e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—SDHD—melanoma	9.89e-06	8.84e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—BSG—melanoma	9.89e-06	8.84e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—CSPG4—melanoma	9.89e-06	8.84e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—MAP2K2—melanoma	9.87e-06	8.83e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—GPAM—melanoma	9.57e-06	8.57e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—VCAN—melanoma	9.47e-06	8.48e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—GNA11—melanoma	9.46e-06	8.46e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—TERT—melanoma	9.38e-06	8.4e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—RAC1—melanoma	9.36e-06	8.37e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—melanoma	9.31e-06	8.33e-05	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—PIK3CD—melanoma	9.29e-06	8.31e-05	CbGpPWpGaD
Clomifene—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	9.27e-06	8.29e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—FASN—melanoma	9.25e-06	8.28e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—ABCB1—melanoma	9.22e-06	8.25e-05	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—ALB—melanoma	9.17e-06	8.2e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—SLC5A5—melanoma	9.1e-06	8.14e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—HIF1A—melanoma	8.97e-06	8.03e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	8.97e-06	8.02e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—GNAQ—melanoma	8.79e-06	7.87e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—CD44—melanoma	8.79e-06	7.87e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—ABCB1—melanoma	8.69e-06	7.78e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	8.66e-06	7.74e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—KDR—melanoma	8.58e-06	7.68e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—PRKCA—melanoma	8.48e-06	7.59e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—CYP1B1—melanoma	8.43e-06	7.54e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—ERCC2—melanoma	8.41e-06	7.53e-05	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—PIK3CG—melanoma	8.41e-06	7.52e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—FN1—melanoma	8.26e-06	7.39e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PLA2G6—melanoma	8.14e-06	7.28e-05	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—PPARG—melanoma	8.11e-06	7.26e-05	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—PIK3CB—melanoma	8.09e-06	7.24e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—NOTCH1—melanoma	8.09e-06	7.23e-05	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—PTGS2—melanoma	8.02e-06	7.18e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—PRKCA—melanoma	8e-06	7.16e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—CYP17A1—melanoma	7.99e-06	7.15e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—ERCC2—melanoma	7.93e-06	7.1e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CD80—melanoma	7.92e-06	7.09e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—APC—melanoma	7.91e-06	7.07e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PIK3CG—melanoma	7.91e-06	7.07e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—KIT—melanoma	7.91e-06	7.07e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	7.88e-06	7.05e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—EGF—melanoma	7.82e-06	6.99e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	7.78e-06	6.96e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—GNA11—melanoma	7.55e-06	6.75e-05	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—PIK3CA—melanoma	7.45e-06	6.66e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—BRAF—melanoma	7.43e-06	6.65e-05	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—PIK3CD—melanoma	7.39e-06	6.61e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—FASN—melanoma	7.39e-06	6.61e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—VCAN—melanoma	7.31e-06	6.54e-05	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—ALB—melanoma	7.3e-06	6.53e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—SLC5A5—melanoma	7.27e-06	6.5e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—IGF1—melanoma	7.24e-06	6.48e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—GNAQ—melanoma	7.02e-06	6.28e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—CD44—melanoma	7.02e-06	6.28e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—MAP2K1—melanoma	7e-06	6.26e-05	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—PTEN—melanoma	6.99e-06	6.26e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PIK3CD—melanoma	6.95e-06	6.22e-05	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—MAPK3—melanoma	6.88e-06	6.16e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	6.87e-06	6.15e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	6.81e-06	6.09e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—CYP1B1—melanoma	6.73e-06	6.02e-05	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—MYC—melanoma	6.69e-06	5.99e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—FGF2—melanoma	6.66e-06	5.95e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—PIK3CG—melanoma	6.64e-06	5.94e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	6.57e-06	5.88e-05	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—PIK3CB—melanoma	6.44e-06	5.76e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—PPARG—melanoma	6.41e-06	5.74e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PRKCA—melanoma	6.39e-06	5.72e-05	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—PTGS2—melanoma	6.38e-06	5.71e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—ERCC2—melanoma	6.33e-06	5.67e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—PIK3CG—melanoma	6.26e-06	5.6e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—MDM2—melanoma	6.23e-06	5.57e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—CYP17A1—melanoma	6.17e-06	5.52e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—ERBB2—melanoma	6.14e-06	5.49e-05	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—AKT1—melanoma	6.08e-06	5.44e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PIK3CB—melanoma	6.06e-06	5.42e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—PPARG—melanoma	6.05e-06	5.41e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	5.94e-06	5.31e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—PIK3CD—melanoma	5.84e-06	5.23e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—GNA11—melanoma	5.83e-06	5.21e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CXCL8—melanoma	5.82e-06	5.21e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—ALB—melanoma	5.77e-06	5.16e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—FASN—melanoma	5.7e-06	5.1e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CDKN1B—melanoma	5.69e-06	5.09e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—SLC5A5—melanoma	5.61e-06	5.02e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CASP3—melanoma	5.57e-06	4.99e-05	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—PTEN—melanoma	5.57e-06	4.98e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—IL2—melanoma	5.56e-06	4.98e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—ABCB1—melanoma	5.54e-06	4.96e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—PIK3CD—melanoma	5.51e-06	4.93e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—ALB—melanoma	5.44e-06	4.86e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CCND1—melanoma	5.42e-06	4.85e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—GNAQ—melanoma	5.42e-06	4.85e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—CD44—melanoma	5.42e-06	4.85e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CTNNB1—melanoma	5.37e-06	4.81e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—MMP9—melanoma	5.27e-06	4.71e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CDKN1A—melanoma	5.25e-06	4.69e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PTEN—melanoma	5.24e-06	4.68e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—NFKB1—melanoma	5.21e-06	4.66e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—CYP1B1—melanoma	5.19e-06	4.65e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PRKCA—melanoma	5.1e-06	4.56e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—PIK3CB—melanoma	5.09e-06	4.56e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—ERCC2—melanoma	5.06e-06	4.52e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—PTGS2—melanoma	5.04e-06	4.51e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PIK3CG—melanoma	5e-06	4.48e-05	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—PIK3CA—melanoma	4.93e-06	4.41e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PPARG—melanoma	4.83e-06	4.32e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—PIK3CB—melanoma	4.8e-06	4.29e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—PTGS2—melanoma	4.76e-06	4.26e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—VEGFA—melanoma	4.73e-06	4.23e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—STAT3—melanoma	4.68e-06	4.19e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—NRAS—melanoma	4.67e-06	4.18e-05	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—AKT1—melanoma	4.64e-06	4.15e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—MAPK3—melanoma	4.47e-06	4e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—PTEN—melanoma	4.4e-06	3.94e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PIK3CD—melanoma	4.4e-06	3.94e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—MYC—melanoma	4.35e-06	3.89e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—ALB—melanoma	4.34e-06	3.88e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—ABCB1—melanoma	4.28e-06	3.83e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—MAPK1—melanoma	4.26e-06	3.81e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—EGFR—melanoma	4.26e-06	3.81e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.19e-06	3.75e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—PTEN—melanoma	4.15e-06	3.71e-05	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—AKT1—melanoma	4.03e-06	3.61e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—KRAS—melanoma	4.02e-06	3.6e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PIK3CG—melanoma	3.99e-06	3.57e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PRKCA—melanoma	3.94e-06	3.52e-05	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—PIK3CA—melanoma	3.93e-06	3.51e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—ERCC2—melanoma	3.9e-06	3.49e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PPARG—melanoma	3.85e-06	3.45e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PIK3CB—melanoma	3.83e-06	3.43e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PTGS2—melanoma	3.8e-06	3.4e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PIK3CA—melanoma	3.69e-06	3.3e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—TP53—melanoma	3.57e-06	3.2e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PIK3CD—melanoma	3.51e-06	3.14e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—ALB—melanoma	3.47e-06	3.1e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—HRAS—melanoma	3.42e-06	3.06e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PTEN—melanoma	3.31e-06	2.96e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—IL6—melanoma	3.27e-06	2.93e-05	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—AKT1—melanoma	3.21e-06	2.87e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—PIK3CA—melanoma	3.1e-06	2.78e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PIK3CG—melanoma	3.08e-06	2.76e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PIK3CB—melanoma	3.06e-06	2.74e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PTGS2—melanoma	3.03e-06	2.71e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—AKT1—melanoma	3.02e-06	2.7e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PPARG—melanoma	2.97e-06	2.66e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—PIK3CA—melanoma	2.93e-06	2.62e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PIK3CD—melanoma	2.71e-06	2.42e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—ALB—melanoma	2.68e-06	2.39e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PTEN—melanoma	2.64e-06	2.37e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—AKT1—melanoma	2.54e-06	2.27e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—AKT1—melanoma	2.39e-06	2.14e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PIK3CB—melanoma	2.36e-06	2.11e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PTGS2—melanoma	2.34e-06	2.09e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PIK3CA—melanoma	2.34e-06	2.09e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PTEN—melanoma	2.04e-06	1.83e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—AKT1—melanoma	1.91e-06	1.71e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PIK3CA—melanoma	1.87e-06	1.67e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—AKT1—melanoma	1.52e-06	1.36e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PIK3CA—melanoma	1.44e-06	1.29e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—AKT1—melanoma	1.18e-06	1.05e-05	CbGpPWpGaD
